Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Europe midday: Shares rise on data; Mpox drug maker Bavarian Nordic surges

(Sharecast News) - European shares were higher as data from the US allayed fears of a potential recission, while upbeat retail sales figures in the UK also boosted sentiment. The pan-regional Stoxx 600 index was up 0.27% at 511.80, rounding off a more positive week for equities after the recent sell-off.

US markets all closed sharply higher overnight as unemployment claims in the US dipped unexpectedly during the previous week. According to the Department of Labor, in seasonally adjusted terms first time jobless claims fell by 7,000 over the week ending on 10 August to reach 227,000. Economists had forecast a slight rise to 235,000.

Retail sales in the world's biggest economy also jumped last month, driven by a rebound in auto purchases. According to the Department of Commerce, in seasonally adjusted terms, retail sales volumes shot 1.0% higher month-on-month to reach $709.7bn. That followed a revised 0.2% decline in June, but was more than twice the 0.3% gain projected by economists.

In the UK, retail sales rebounded to 0.5% growth in July from a 0.9% decline in the previous month, in line with expectations.

On the equities front, shares in Nibe were up as the Swedish heat pump maker reported first-half earnings.

Shares in Bavarian Nordic, which makes the Imvanex mpox vaccine surged by 16% as the first case of a more dangerous variant of the disease was reported in Asia.

The drugmaker on Friday said it was seeking approval from the European Union regulator for the jab - currently licensed only for adults - to be given to children aged 12 to 17.

Shares in German chemicals maker Bayer also jumped after a US appeals court said it was protected under federal law which would limit liability from claims that its Roundup weed killer causes cancer.

The case was brought by David Schaffner, a Pennsylvania landscaper diagnosed with non-Hodgkins lymphoma in 2006, who claimed the Bayer had failed to provide a cancer warning on the label of Roundup.

However, the US Circuit Court of Appeals in Philadelphia ruled that the Federal Insecticide, Fungicide, and Rodenticide Act required nationwide uniformity in pesticide labels, and stopped Pennsylvania from adding a cancer warning.

Shares in video game maker Embracer Group rallied a day after the company reported a sharp fall in first-quarter sales.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

London midday: Stocks stay down as China retaliates against US tariffs
(Sharecast News) - London stocks were still in the red by midday on Tuesday as investors mulled the impact of the latest developments in the Trump tariff drama, after China announced retaliatory tariffs on a range of US imports.
Europe midday: Shares pare losses as investors digest China tariff move
(Sharecast News) - European stocks pared losses as investors digested China's retaliatory moves against US tariffs and the 30-day pause on levies against Canada and Mexico.
US pre-open: Futures slightly lower as tariff headlines remain in focus
(Sharecast News) - Wall Street futures were in the red ahead of the bell on Tuesday as the effects of the new White House administration's tariffs on a number of its closest trading partners continued to be seen.
Asia report: Markets bounce back from Trump tariff sell-off
(Sharecast News) - Asia-Pacific markets advanced on Tuesday as investor sentiment improved following Donald Trump's decision to pause tariffs on Mexico and Canada for a month.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.